iRhythm Sets IPO Pricing Range
San Francisco-based iRhythm, which develops cardiac monitoring systems, said in a filing on Friday that it expects it IPO to price at between $13.00 and $15.00 per share. The company is selling 5,350,000 shares of its common stock in its offering, and has applied to list as IRTC on the NASDAQ Global Market. The company's IPO is being underwritten by J.P. Morgan, Morgan Stanley, Canaccord Genuity, and BTIG. iRhythm is backed by Synergy Life Science Partners, Norwest Ventures, Novo A/S, New Leaf, MDV-Relevation, Kaiser Permanente, St. Jude Medical, and others.
posted on Monday, October 10, 2016
Related companies:
IRhythm Technologies
Related stories:
> iRhythm Technologies Snags $10M
> iRhythm Finds $17M
> iRhythm Taps Into $16M For Heart Rate Monitoring
> Ooma Sets IPO Pricing Range
> Facebook Sets IPO Pricing Range
silicontap.com Home